{"product_id":"cjc-ipa","title":"CJC + IPAMORELIN 10mg","description":"\u003cp data-end=\"760\" data-start=\"268\"\u003e\u003cstrong data-end=\"289\" data-start=\"268\"\u003eCJC‑1295 (No DAC)\u003c\/strong\u003e (Modified GRF 1‑29) is a growth hormone‑releasing hormone (GHRH) analogue engineered to activate the hypothalamic‑pituitary GH axis in a \u003cem data-end=\"438\" data-start=\"427\"\u003epulsatile\u003c\/em\u003e fashion. \u003cstrong data-end=\"462\" data-start=\"448\"\u003eIpamorelin\u003c\/strong\u003e is a selective ghrelin‑receptor agonist (GHS‑R1a) designed to stimulate growth hormone (GH) release with minimal effects on cortisol or prolactin. When combined, these peptides act through \u003cem data-end=\"689\" data-start=\"652\"\u003edistinct yet complementary pathways\u003c\/em\u003e to enhance endogenous GH secretion more effectively than either alone.\u003c\/p\u003e\n\u003cp data-end=\"925\" data-start=\"762\"\u003eThis synergistic peptide stack is studied in research exploring GH modulation, neuroendocrine signaling, tissue biology, body composition, and recovery mechanisms.\u003c\/p\u003e\n\u003chr data-end=\"930\" data-start=\"927\"\u003e\n\u003cp data-end=\"952\" data-start=\"932\"\u003e\u003cstrong data-end=\"952\" data-start=\"936\"\u003eKey Features\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"1168\" data-start=\"954\"\u003e🧬 cGMP manufactured in an FDA‑registered facility\u003cbr data-end=\"1007\" data-start=\"1004\"\u003e📊 ≥98% purity confirmed by HPLC analysis\u003cbr data-end=\"1051\" data-start=\"1048\"\u003e📄 Batch‑specific Certificates of Analysis (COAs) included\u003cbr data-end=\"1112\" data-start=\"1109\"\u003e✒️ Pre‑filled sterile peptide pens for research use only\u003c\/p\u003e\n\u003chr data-end=\"1173\" data-start=\"1170\"\u003e\n\u003cp data-end=\"1219\" data-start=\"1175\"\u003e\u003cstrong data-end=\"1219\" data-start=\"1179\"\u003eHuman-Relevant Research Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"1525\" data-start=\"1221\"\u003e🔬 \u003cstrong data-end=\"1275\" data-start=\"1224\"\u003eSelective GH secretagogue activity - Ipamorelin\u003c\/strong\u003e\u003cbr data-end=\"1278\" data-start=\"1275\"\u003eHuman studies demonstrate that Ipamorelin stimulates GH release via the ghrelin receptor with minimal effects on cortisol or prolactin, making it a highly selective secretagogue for research purposes.\u003cbr data-end=\"1481\" data-start=\"1478\"\u003e🔗 \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10496658\/?utm_source=chatgpt.com\" class=\"decorated-link\" rel=\"noopener\" data-end=\"1525\" data-start=\"1484\"\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/10496658\/\u003cspan class=\"ms-0.5 inline-block align-middle leading-none\" aria-hidden=\"true\"\u003e\u003csvg class=\"block h-[0.75em] w-[0.75em] stroke-current stroke-[0.75]\" data-rtl-flip=\"\" aria-hidden=\"true\" height=\"20\" width=\"20\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\u003e\u003cuse fill=\"currentColor\" href=\"\/cdn\/assets\/sprites-core-c9exbsc1.svg#304883\"\u003e\u003c\/use\u003e\u003c\/svg\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"1901\" data-start=\"1527\"\u003e🔬 \u003cstrong data-end=\"1572\" data-start=\"1530\"\u003eSynergistic dual-pathway GH modulation\u003c\/strong\u003e\u003cbr data-end=\"1575\" data-start=\"1572\"\u003eMechanistic research shows that combining a GHRH analogue (CJC‑1295 No DAC) with a GHS‑R agonist (Ipamorelin) targets complementary receptors, producing more robust and physiologically pulsatile GH signaling than either agent alone in controlled experimental settings.\u003cbr data-end=\"1846\" data-start=\"1843\"\u003e🔗 \u003ca href=\"https:\/\/peptpedia.org\/compare\/cjc-1295-vs-ipamorelin?utm_source=chatgpt.com\" class=\"decorated-link\" rel=\"noopener\" data-end=\"1901\" data-start=\"1849\"\u003ehttps:\/\/peptpedia.org\/compare\/cjc-1295-vs-ipamorelin\u003cspan class=\"ms-0.5 inline-block align-middle leading-none\" aria-hidden=\"true\"\u003e\u003csvg class=\"block h-[0.75em] w-[0.75em] stroke-current stroke-[0.75]\" data-rtl-flip=\"\" aria-hidden=\"true\" height=\"20\" width=\"20\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\u003e\u003cuse fill=\"currentColor\" href=\"\/cdn\/assets\/sprites-core-c9exbsc1.svg#304883\"\u003e\u003c\/use\u003e\u003c\/svg\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003chr data-end=\"1906\" data-start=\"1903\"\u003e\n\u003cp data-end=\"1962\" data-start=\"1908\"\u003e\u003cstrong data-end=\"1962\" data-start=\"1912\"\u003eKey Benefits of CJC‑1295 + Ipamorelin\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"2103\" data-start=\"1964\"\u003e💥 \u003cstrong data-end=\"2001\" data-start=\"1967\"\u003eEnhanced Endogenous GH Release\u003c\/strong\u003e – Dual-pathway stimulation amplifies growth hormone secretion compared with single-agent protocols.\u003c\/p\u003e\n\u003cp data-end=\"2234\" data-start=\"2105\"\u003e🧪 \u003cstrong data-end=\"2145\" data-start=\"2108\"\u003eSynergistic Neuroendocrine Action\u003c\/strong\u003e – Targets both GHRH and ghrelin receptors to explore complementary GH axis regulation.\u003c\/p\u003e\n\u003cp data-end=\"2357\" data-start=\"2236\"\u003e⚖️ \u003cstrong data-end=\"2280\" data-start=\"2239\"\u003eSupports Physiological GH Pulsatility\u003c\/strong\u003e – Mimics natural GH release patterns for more realistic research modeling.\u003c\/p\u003e\n\u003cp data-end=\"2522\" data-start=\"2359\"\u003e🧬 \u003cstrong data-end=\"2397\" data-start=\"2362\"\u003eVersatile Research Applications\u003c\/strong\u003e – Enables investigation into GH-mediated effects on body composition, tissue recovery, metabolism, and anabolic signaling.\u003c\/p\u003e\n\u003cp data-end=\"2668\" data-start=\"2524\"\u003e🔍 \u003cstrong data-end=\"2559\" data-start=\"2527\"\u003eSelective Hormone Modulation\u003c\/strong\u003e – Ipamorelin’s receptor specificity minimizes off-target hormone elevations, improving experimental clarity.\u003c\/p\u003e\n\u003chr data-end=\"2673\" data-start=\"2670\"\u003e\n\u003cp data-end=\"2700\" data-start=\"2675\"\u003e\u003cstrong data-end=\"2700\" data-start=\"2679\"\u003eMechanism Summary\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"3120\" data-start=\"2702\"\u003e• \u003cstrong data-end=\"2725\" data-start=\"2704\"\u003eCJC‑1295 (No DAC)\u003c\/strong\u003e binds to GHRH receptors on pituitary somatotrophs, stimulating GH synthesis and release through hypothalamic pathways.\u003cbr data-end=\"2847\" data-start=\"2844\"\u003e• \u003cstrong data-end=\"2863\" data-start=\"2849\"\u003eIpamorelin\u003c\/strong\u003e binds selectively to the ghrelin receptor (GHS‑R1a), triggering GH release with minimal impact on cortisol and prolactin.\u003cbr data-end=\"2988\" data-start=\"2985\"\u003e• The \u003cstrong data-end=\"3045\" data-start=\"2994\"\u003ecombination targets two complementary receptors\u003c\/strong\u003e, providing enhanced pulsatile GH release compared with single-agent use.\u003c\/p\u003e","brand":"Limitless Wellness Lab","offers":[{"title":"Default Title","offer_id":47857031020782,"sku":null,"price":450.0,"currency_code":"AED","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0697\/5917\/2846\/files\/WhatsAppImage2026-04-12at18.33.46_d47b7014-4927-4721-bb3b-f43e780c8cbd.jpg?v=1776074659","url":"https:\/\/syncom.shop\/ar\/products\/cjc-ipa","provider":"Limitless Wellness Lab","version":"1.0","type":"link"}